DOCGO INC Stock Price, News & Analysis

DocGo (Nasdaq: DCGO) said management will participate in four investor conferences in November 2025: the 17th Annual Southwest Ideas Conference on November 19, Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum on November 20, Needham Sixth Annual Tech Week on November 21, and the BTIG Digital Health Forum on November 24.

CFO Norm Rosenberg will present at the Southwest Ideas Conference on Nov 19 at 2:20 PM ET with a webcast available on DocGo’s investor relations site. CEO Lee Bienstock and CFO Norm Rosenberg are scheduled for 1x1 meetings at the Canaccord and Needham events. CEO Bienstock will join a BTIG panel on Care Gap Closure and Mobile Health Support at 11:00 AM ET on Nov 24.

DocGo (Nasdaq: DCGO) reported third quarter 2025 results with total revenue $70.8M, down from $138.7M a year ago due to the wind-down of migrant-related programs.

Excluding migrant-related revenue, core revenue rose 8% to $62.4M. GAAP gross margin was 20.0% and adjusted gross margin was 33.0%. Net loss was $29.7M, which included $16.7M of non-cash impairments. Adjusted EBITDA loss was $7.2M. Cash and equivalents were $95.2M as of Sept 30, 2025, after repaying a $30M line of credit; operating cash flow was $1.7M for the quarter.

Company reported record volumes across major lines (transportation +2.5%, care gap +320%, phlebotomy +11%, RPM +6%), completed the acquisition of SteadyMD, and provided 2025 and 2026 guidance: 2025 revenue $315–320M (including $68–70M migrant revenue) and adjusted EBITDA loss $25–28M; 2026 revenue $280–300M with adjusted EBITDA loss $15–25M.

DocGo (Nasdaq: DCGO) announced a partnership with a California health plan to launch Longitudinal Care Services targeting 10,000 under‑engaged plan members. The program combines on‑site mobile clinicians and telehealth to deliver preventive care, chronic care management and transitions of care, with clinicians using connected diagnostic equipment supervised by virtual advanced practice providers. The expansion with a current partner is expected to launch in Q4 2025 and aims to address care gaps that drive ER use and worsening chronic conditions.

The company highlighted its 50‑state virtual care platform, mobile health and ambulance services as supporting capabilities and included a forward‑looking disclaimer about risks and uncertainties.

DocGo (Nasdaq: DCGO) will release third quarter 2025 results for the period ended September 30, 2025 after market close on Monday, November 10, 2025.

Management will host a conference call and webcast the same day at 5:00 p.m. ET. Dial-in numbers: 1-800-717-1738 (U.S.) and 1-646-307-1865 (international); Conference ID: 87106. A webcast will be available under Events in the Investors section at https://ir.docgo.com/. The release covers Q3 2025 financial results and a management discussion on performance and outlook.

DocGo (Nasdaq: DCGO) announced the acquisition of virtual care platform SteadyMD, combining DocGo’s mobile health and medical transportation services with SteadyMD’s 50-state telehealth platform.

Key disclosed metrics: SteadyMD is expected to service ~3 million patients in 2025, maintain a roster of > 600 clinicians, and generate approximately $25 million revenue in 2025; SteadyMD is expected to be EBITDA positive in 2026. DocGo plans to fund the transaction from existing cash and will update 2025 revenue and adjusted EBITDA guidance in early November. SteadyMD founders are joining DocGo leadership.

DocGo (Nasdaq: DCGO) will launch a care gap closure program in New Mexico covering 10,000 Turquoise Care enrollees through an expanded partnership with a national insurance provider. The initiative will deliver technology‑enabled, in‑home services including well child visits, vaccinations, hypertension and diabetic control assessments, and plans to introduce primary care services for members.

The program leverages DocGo’s mobile clinicians and platform, targets closing nearly 50 care gaps, and aims to reengage patients with the health care system to improve access and outcomes.

DocGo (Nasdaq: DCGO), a technology-enabled mobile health and medical transportation services provider, has announced its participation in three upcoming investor conferences.

The company will participate in the Three Part Advisors Midwest on August 26th, where CFO Norm Rosenberg will present at 11:30 AM CT. CEO Lee Bienstock will attend the Cantor Global Healthcare Conference on September 3rd at 10:20 AM ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10th at 9:15 AM ET. All events will include 1x1 meetings and webcasts available on DocGo's investor relations website.

DocGo (Nasdaq: DCGO) reported Q2 2025 financial results, with total revenue of $80.4 million, down from $164.9 million in Q2 2024, primarily due to planned wind-down of migrant-related programs. The company posted a net loss of $13.3 million and Adjusted EBITDA loss of $6.1 million.

Key highlights include increased total cash balance to $128.7 million, surpassing 1.2 million patients assigned for care gap closure services, and expansion of healthcare partnerships. The company maintained its 2025 guidance of $300-$330 million in revenue and adjusted EBITDA loss of $20-$30 million. DocGo implemented cost-cutting measures, targeting $10 million in annual savings, and expects to achieve profitability in H2 2026.

The company continues expanding its payer and provider business, launching new care gap closure programs and medical transportation services across multiple states.

DocGo (Nasdaq: DCGO) has secured a new contract with a major New York metro area academic medical system to provide its technology-enabled transportation management platform and dedicated ambulance services. The company's proprietary software will be used for centralized management of all patient discharges across the health system.

Through its Ambulnz brand, DocGo will provide basic life support (BLS) ambulance services at select facilities. The platform integrates with the health system's electronic health records, enabling automated patient data transfer and consolidated reporting. Services began in July 2025 with planned expansion throughout the quarter.